HOME › DRUGS › EMTRICITABINE;RILPIVIRINE;TENOFOVIR DISOPROXIL
ACTIVE SUBSTANCE / INN

EMTRICITABINE;RILPIVIRINE;TENOFOVIR DISOPROXIL

Brand name(s): Eviplera
EMA LISTED
AUTHORISED
HIV Infections
ACTIVE SUBSTANCE
Emtricitabine;Rilpivirine;Tenofovir Disoproxil
REGULATORS
EMA
SPONSORS / MAH
Gilead Sciences International Ltd 
TOTAL APPLICATIONS
1
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
EvipleraGilead Sciences International Ltd Authorised27/11/2011HIV Infections

FULL INTELLIGENCE ON EMTRICITABINE;RILPIVIRINE;TENOFOVIR DISOPROXIL

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →